Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 18 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Method of hydrothermal liquid phase sintering of ceramic materials and products derived therefrom
Cell surface display, screening and production of proteins of interest
Systems and methods for mitigating spectral regrowth from non-linear systems
Method and apparatus for transmitting and receiving extension information of component carrier in wireless communication system
Systems and methods for economic retirement analysis
Flood protection apparatus and container data center including the same
  Randomly Featured Patents
Tapered fiber bundles for coupling light into and out of cladding-pumped fiber devices
Mosquito development inhibitor employing substituted phenols
Method of operating an AC-DC converter
Self-aligning piston
Resistance-change memory device
Corrosion inhibiting phase change ink jet inks
Method and an apparatus for automatically tuning a process regulator
Insulation board
Arrangement in connection with an adjustable back rest cushion of a chair
Methods, mobile stations, and systems for determining base station identifier codes for handover candidates in a network